drugset / Trial / NCT02772120

Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles

NCT02772120

Phase 4 Withdrawn Brigham and Women's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to test the hypothesis that the pregnancy rates of women (ages 18-50 years) undergoing transfer of vitrified-warmed blastocysts (frozen at less than 41 years of age) as part of their IVF treatment are not different with respect to the administration of progesterone (Crinone® 8% vaginal gel versus intramuscular progesterone).

Timeline

Start
Primary completion
2019-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 50 mg Other
Comparator Progesterone Other / unclassified 90 mg Other

Indications